PATENT CLAIM ANALYSIS

Application Number: 16255769
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["424", "139100"]

Abstract:
Disclosed herein are antibodies specific to a delta1 chain of a γδ T cell receptor and methods of using such for modulating γδ T cell bioactivity. Such anti-Delta1 antibodies may also be used to treat diseases associated with γδ T cell activation, such as solid tumors, or for detecting presence of γδ1 T cells.

Claim (Index 2):
The isolated antibody of  claim 1 , wherein the antibody comprises a heavy chain variable domain (V H ) comprising a heavy chain CDR1 (HC CDR1), a heavy chain CDR2 (HC CDR2), and a heavy chain CDR3 (HC CDR3), wherein the HC CDR1 comprises sequence selected from any of SEQ ID NOs: 43, 49, 53, 60, and 64, the HC CDR2 comprises sequence selected from any of SEQ ID NOs: 44, 50, 54, 57, 61, 65, 68, and 72, and the HC CDR3 comprises sequence selected from any of SEQ ID NOs: 45, 51, 55, 58, 62, 66, 69, 71, 73, 75, 76, and 77.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 99.0
- Lexical Diversity: 1.38095
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['16173970', '15271861', '16175453', '15034782', '15712010']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7683127839687766
- 35 USC 102 Novelty (BERT): 0.5602598170550844
- Combined Prediction Score: 0.7475074872774073
- Mean Citation Score: 435.944402
- Max Citation Score: 467.11746
- Similarity Product: 346.4457873207593

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test